Fundraising Fox
Digital Bio
18 known investors
Find your way into Digital Bio
Sign up to see every warm intro you have to Digital Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Digital Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
Investors · 18
How we know: Fifty Years's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
Also in the syndicate · 11
Funding
SEC filings, press & company announcements$3M disclosed across 1 of 3 rounds · 2024–2026
- $3MraisedMar 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Digital Bio do?
- Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
- Who are Digital Bio's investors?
- Digital Bio's investors include Fifty Years, A91 Partners, Goldman Sachs, HSBC, Morgan Stanley, Peak XV Partners, Steadview Capital.
- How much funding has Digital Bio raised?
- Digital Bio has disclosed $3M raised across 1 of its 3 known rounds.